What is the prevalence of Lymphoedema?

Lymphoedema prevalence is difficult to quantify due to significant underdiagnosis, but secondary lymphoedema is considered common globally, while primary lymphoedema is classified as rare. Estimates vary widely, with some studies suggesting the condition affects millions worldwide, though specific incidence rates remain challenging to pinpoint due to varied diagnostic criteria.

Is Lymphoedema considered a rare disease?

The classification of Lymphoedema depends on its cause. Secondary Lymphoedema, often resulting from cancer treatments or parasitic infections like lymphatic filariasis, is quite common on a global scale. In contrast, primary Lymphoedema—caused by genetic mutations affecting lymphatic system development—is considered a rare disease. Because primary Lymphoedema often presents in infancy or puberty, it is frequently tracked in rare disease registries, whereas secondary cases are often managed within oncology or vascular departments.

How does the prevalence of Lymphoedema vary by gender and age?

Epidemiological data indicates that Lymphoedema affects females more frequently than males, particularly in cases linked to breast cancer treatment or specific genetic conditions like Milroy disease. Regarding age of onset, Lymphoedema can manifest at any stage of life:

• Primary Lymphoedema: Often appears at birth (congenital), during puberty (praecox), or in adulthood (tarda).


• Secondary Lymphoedema: Typically occurs following surgery, radiation therapy, or trauma, and can develop months or even years after the initial insult.

Why is accurate data on Lymphoedema prevalence challenging to track?

Quantifying the exact number of people living with Lymphoedema is notoriously difficult. Many cases are misdiagnosed as generalized edema or venous insufficiency, leading to an underestimation of the true burden. At DiseaseMaps.org, we have seen 86 members join our community to share their experiences, providing a vital real-world perspective that clinical literature often overlooks. This community data underscores that while medical texts may provide broad statistics, the lived experience of those with Lymphoedema reflects a diverse range of diagnostic journeys and global health disparities.

Next steps

• Consult a vascular specialist or a certified lymphedema therapist (CLT) if you notice persistent swelling.


• Join the Lymphoedema community at DiseaseMaps.org to connect with others and share experiences.


• Keep a symptom log to track the progression of swelling, which assists physicians in accurate diagnosis.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Lymphoedema.


• Orphanet: Primary lymphedema (ORPHA:537).


• International Society of Lymphology (ISL) Consensus Document.


• Lymphatic Education & Research Network (LE&RN).